220913-32-6 ((1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy-, (4S)-)

结构式：

1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy-, (4S)-MOL文件

CAS号：

220913-32-6

英文名称：

1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy-, (4S)-

分子式：

C₂₆H₃₀N₂O₅Si

分子量：

478.61230802536

1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy-, (4S)-(220913-32-6)名称与标识符

名称

英文别名：

1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy-, (4S)-;1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy;AR-67;DB 67;(20S)-10-hydroxy-7-tert-butyldimethylsilylcamptothecin;(20S)-7-t-Butyldimethylsilyl-10-hydroxycamptothecin;20(S)-7-tert-butyldimethylsilyl-10-hydroxycamptothecin;7-tert-butyldimethylsilyl-10-hydroxy-camptothecin;AR67;AR-67 lactone;CHEMBL412309;NCI60_038363;SureCN1266162;UNII-3YEA04NV6H;NSC 708298;NSC708298;DB-67;NS00073563;(20S)-7-TERT-BUTYLDIMETHYSILYL-10-HYDROXYCAMPTOTHECIN;DB12384;compound 14 [PMID:11052802];DTXSID00176592;3YEA04NV6H;(S)-11-(tert-Butyldimethylsilyl)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;Q27074492;1H-Pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione, 11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy-, (4S)-;AR-67 cpd;NSC-708298;(19S)-10-[tert-butyl(dimethyl)silyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;AR 67;SCHEMBL1266162;DB 67; Silatecan;AR 67 cpd;1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 11-((1,1-dimethylethyl)dimethylsilyl)-4-ethyl-4,9-dihydroxy-, (4S)-;Silatecan;DB67;GTPL8919;220913-32-6;Silatecan AR-67;(19S)-10-(tert-butyldimethylsilyl)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.0^(2,11).0^(4,9).0^(15,20))henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione;7-t-butyldimethylsilyl-10-hydroxycamptothecin;(19S)-10-(tert-butyldimethylsilyl)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione;compound 14 (PMID:11052802);HY-16055;DTXCID4099083;CS-0006130;1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)- dione, 11-((1,1-dimethylethyl)dimethylsilyl)-4-ethyl-4,9- dihydroxy-, (4S)-;

标识符

InChIKey：

XUSKJHCMMWAAHV-SANMLTNESA-N

Inchi：

1S/C26H30N2O5Si/c1-7-26(32)18-11-20-21-16(12-28(20)23(30)17(18)13-33-24(26)31)22(34(5,6)25(2,3)4)15-10-14(29)8-9-19(15)27-21/h8-11,29,32H,7,12-13H2,1-6H3/t26-/m0/s1

SMILES：

[Si](C)(C)(C1C2C=C(C=CC=2N=C2C3=CC4[C@](C(=O)OCC=4C(N3CC=12)=O)(CC)O)O)C(C)(C)C

1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy-, (4S)-(220913-32-6)物化性质

实验特性

LogP : 3.50070
PSA : 99.96
折射率 : 1.636
沸点 : 740°Cat760mmHg
闪点 : 401.3°C
密度 : 1.32

计算特性

精确分子量 : 478.1925
氢键供体数量 : 2
氢键受体数量 : 7
可旋转化学键数量 : 3
同位素质量 : 478.192399
重原子数量 : 34
复杂度 : 982
同位素原子数量 : 0
确定原子立构中心数量 : 1
不确定原子立构中心数量 : 0
确定化学键立构中心数量 : 0
不确定化学键立构中心数量 : 0
共价键单元数量 : 1
拓扑分子极性表面积 : 100

1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy-, (4S)-(220913-32-6)推荐厂家更多厂家(3)

公司名称	手机号/电话	联系人	QQ	询单
上海瀚思化工有限公司	18939883912 021-34536277	顾经理	3003949364	询单
上海阿拉丁生化科技股份有限公司	13167063860 13167063860	阿拉丁	3004013043	询单
武汉市星熠艾克生物医药有限责任公司		胡小姐		询单

1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy-, (4S)-(220913-32-6)相关文献

1. N-Hydroxy and N-acyloxy peptides: synthesis and chemical modifications
James Lawrence,Laure Cointeaux,Pascal Maire,Yannick Vallée,Véronique Blandin Org. Biomol. Chem. 2006 4 3125
2. Selective conversion of polyethylene wastes to methylated aromatics through cascade catalysis
Jindi Duan,Hai Wang,Hangjie Li,Lujie Liu,Kai Fan,Xiangju Meng,Zhiguo Zhang,Liang Wang,Feng-Shou Xiao EES. Catal. 2023 1 529
3. Synthesis of thiodisaccharides related to 4-thiolactose. Specific structural modifications increase the inhibitory activity against E. coli β-galactosidase
Lucas Dada,Juan Pablo Colomer,Verónica E. Manzano,Oscar Varela Org. Biomol. Chem. 2023 21 2188
4. A short, versatile chemical synthesis of l- and d-amino acids stereoselectively labelled solely in the beta position
Kreingkrai Lowpetch,Douglas W. Young Org. Biomol. Chem. 2005 3 3348
5. Insights into the mechanism for gold catalysis: behaviour of gold(i) amide complexes in solution
Mariusz Bobin,Iain J. Day,Stephen M. Roe,Eddy M. E. Viseux Dalton Trans. 2013 42 6592
6. Tributyltin hydride-mediated radical cyclisation of carbonyls to form functionalised oxygen and nitrogen heterocycles
Jon Bentley,Paul A. Nilsson,Andrew F. Parsons J. Chem. Soc. Perkin Trans. 1 2002 1461
7. Studies on gold(i) and gold(iii) alcohol functionalised NHC complexes
Helgi Freyr Jónsson,Andreas Orthaber,Anne Fiksdahl Dalton Trans. 2021 50 5128
8. Silver comes into play: Henry reaction and domino cycloisomerisation sequence catalysed by [Ag(i)(Pc-L)] complexes
Giorgio Tseberlidis,Monica Dell'Acqua,Daniele Valcarenghi,Emma Gallo,Elisabetta Rossi,Giorgio Abbiati,Alessandro Caselli RSC Adv. 2016 6 97404
9. Polymer-supported manganese porphyrin catalysts—peptide-linker promoted chemoselectivity
Emilie Brulé,King Kuok (Mimi) Hii,Yolanda R. de Miguel Org. Biomol. Chem. 2005 3 1971
10. Exploring synthetic and therapeutic prospects of new thiazoline derivatives as aldose reductase (ALR2) inhibitors
Muhammad Tariq Shehzad,Aqeel Imran,Abdul Hameed,Mariya al Rashida,Marium Bibi,Maliha Uroos,Asnuzilawati Asari,Shafia Iftikhar,Habsah Mohamad,Muhammad Nawaz Tahir,Zahid Shafiq,Jamshed Iqbal RSC Adv. 2021 11 17259

81059-04-3(3-[(2-tert-butyl-5-methoxy-1,3-benzothiazol-6-yl)carbamothioylsulfanyl]propanoic acid) 81882-18-0(1-benzofuran-2-ylmethanamine;hydrochloride) 81720-06-1([(1aS,1bα,5aα,6aβ)-2α-(β-D-Glucopyranosyloxy)-1a,1b,2,5a,6,6a-hexahydro-1aβ-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-6α-yl]α-D-galactopyranoside) 81840-57-5(（1E）-1-（4-羟基-3-甲氧基苯基）-7-苯基庚-1-烯-3-酮) 819058-89-4(4-(4-氨基苯基)-1H-吲唑-3-胺) 81964-65-0(1-乙酰基-5-溴-1H-吲哚-2,3-二酮) 819-52-3(氯磺酸正丙酯) 81998-03-0(4,4'-二甲基-2,2'-联吡啶1-氧化物)

960化工网为您提供1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy-, (4S)-专业化合物百科信息，包括中文名，英文名，分子式，分子量，以及该化合物的CasNo.220913-32-6,相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等。 WAP版:220913-32-6 国际站:220913-32-6